- Messages
- 19
- Type of diabetes
- Type 1
- Treatment type
- Insulin
- Dislikes
- Tabloid newspapers, Right wing politics, Semolina
Hi all You may or may not be aware that there's a bit of a battle going on in the long acting insulin world. Up till now Lantus has cornered the lion's share of the market, but Lilly is about to introduce Peglispro (how do they come up with these names) Apparently it demonstrates improved night time performance regarding hypo avoidance and long term better HBa1c's. However for me, the big difference and why I will swap if I can is that I'll then be able to use Lilly's brilliant memoir pen which tells me when I last injected and how much. (Actually it stores the last 16 results) I already use this pen for my Lilly Humalog. What do you all think, is the availability of a potentially life saving memory pen enough incentive to give this new insulin a whirl? I believe that it is scheduled to come on stream before the end of 2015.
And no I don't work for Lilly, I'm just really annoyed that the manufacturers of insulin deliver systems don't realise that for us who may be taking insulin 5 times a day, remembering whether you've actually taken it is a real issue. And no diaries don't help, because 'Did I take it, but not write up my diary' or Did I write it in, but then forget to actually take it etc etc.
And no I don't work for Lilly, I'm just really annoyed that the manufacturers of insulin deliver systems don't realise that for us who may be taking insulin 5 times a day, remembering whether you've actually taken it is a real issue. And no diaries don't help, because 'Did I take it, but not write up my diary' or Did I write it in, but then forget to actually take it etc etc.